The SpectralMD DeepView Wound Imaging System 2.0 is a medical imaging device that uses non-contact photoplethysmography (PPG) technology to capture color images showing blood perfusion in tissues. It helps clinicians assess blood flow in a variety of clinical settings, including wound healing, plastic surgery, and vascular surgery, by providing detailed images of microcirculation in healthy or injured skin.
The SpectralMD™ DeepView™ Wound Imaging System 2.0 is an optical imaging device intended for studies of blood flow in the microcirculation. It is suitable for plastic surgery, diabetes, dermatology, vascular surgery, wound healing, neurology, physiology, neurosurgery, and anesthetics. It measures perfusion of healthy and injured skin including burn wounds, skin flaps, chronic wounds, decubitus ulcers, and diabetic ulcers.
The device utilizes non-contact photoplethysmography (PPG) with LED broadband illumination (400-900 nm) to detect pulsatile blood flow and produce 2D color images of relative blood perfusion. It includes a camera head with LED optics, articulating arm, touchscreen display, and a mobile cart housing hardware and software, with ergonomic and software improvements compared to predicate devices.
Testing demonstrated the device can detect pulsatile blood flow and AC modulation consistent with tissue-volume changes from blood flow. It showed equivalence to the primary predicate device in detecting pulsatile flow frequency and flow under simulated physiological conditions. Electrical safety, electromagnetic compatibility, and usability testing met relevant standards. No clinical data were required to support equivalence.
No predicate devices specified
Submission
11/28/2016
FDA Approval
8/17/2017
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.